FDA Drug Recalls

Recalls / Class II

Class IID-0281-2022

Product

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50

Affected lot / code info
Lot #: 13058, Exp. date 02/2022 and 13768, Exp. date 05/2022

Why it was recalled

CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.

Recalling firm

Firm
Teligent Pharma, Inc.
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
105 Lincoln Avenue, Buena, New Jersey 08310

Distribution

Quantity
14,664 glass bottles
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2021-10-12
FDA classified
2021-12-13
Posted by FDA
2021-12-22
Terminated
2024-06-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0281-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls